Avanti Researcha Brand Under Crodais A Biotechnology Company Based In Alabasteralabamafounded In 1967 As Avanti Polar Lipidsthe Company Rebranded In September 2024 To Reflect Its Expanded Focus On Lipid Based Research Productspolymersformulation Toolsand Delivery Systems For Next Generation Therapeuticsas A Subsidiary Of Croda International Plc Avanti Leverages Global Infrastructure To Enhance Its Cgmp Manufacturing And Life Sciences Capabilities The Company Offers Over 2 000 Highly Purified Lipids For Researchdiagnosticsand Drug Deliveryalong With Custom Lipid Synthesisavanti Provides Cgmp Manufacturing For Clinical Grade Lipid Productionessential For Vaccines And Nucleic Acid Therapiestheir Analytical Services Include Lipidomics And Quality Controlwhile Formulation Development Tools Support Nucleic Acidproteinand Small Molecule Delivery Systemsavanti Serves A Diverse Clienteleincluding Academic Institutionsbiotech Firmsand Pharmaceutical Companiesand Has Played A Significant Role In Developing Lipid Nanoparticles For Covid 19 Vaccines
